Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Administration of Aspirin After Systemic Thrombolysis in Acute Ischemic Stroke
NCT02921360Unknown
- Sponsor
- City Clinical Hospital No. 67
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of aspirin in ischemic stroke (2 arms), sponsored by City Clinical Hospital No. 67. Primary endpoints: All-cause mortality at 3 months, Ischemic events at 3 months and 1 more. Status: unknown.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02921360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02921360.